[Skip to Content]
[Skip to Content Landing]
Views 99
Correction
August 23, 2019

Errors in Tables 3 and 4

JAMA Netw Open. 2019;2(8):e1911452. doi:10.1001/jamanetworkopen.2019.11452

In the Original Investigation titled “Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments,”1 published on July 5, 2019, there were 7 numeric errors in Table 3 in the “Mean” column and 8 numeric errors in Table 4 in the “Manufacturer Aggregate Revenue” column and 8 in the “340B Entity Aggregate Revenue” column. These table values did not match the values in the Results section. This article has been corrected.1

References
1.
Dickson  S, Reynolds  I.  Estimated changes in manufacturer and health care organization revenue following list price reductions for hepatitis C treatments.  JAMA Netw Open. 2019;2(7):e196541. doi:10.1001/jamanetworkopen.2019.6541PubMedGoogle ScholarCrossref
×